4//SEC Filing
Foster Jonathan P. 4
Accession 0001437749-25-020803
CIK 0001659617other
Filed
Jun 17, 8:00 PM ET
Accepted
Jun 18, 9:01 PM ET
Size
8.2 KB
Accession
0001437749-25-020803
Insider Transaction Report
Form 4
Foster Jonathan P.
EVP & CFO
Transactions
- Tax Payment
Common Stock
2025-06-16$0.69/sh−203$139→ 11,993 total - Exercise/Conversion
Restricted Stock Units
2025-06-16−833→ 230,684 total→ Common Stock (833 underlying) - Exercise/Conversion
Common Stock
2025-06-16+833→ 12,196 total
Footnotes (3)
- [F1]Restricted stock units convert into common stock on a one-for-one basis.
- [F2]Shares withheld for payment of taxes upon vesting of restricted stock unit awards.
- [F3]On June 16, 2021, the reporting person was granted 3,334 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date.
Documents
Issuer
Moleculin Biotech, Inc.
CIK 0001659617
Entity typeother
Related Parties
1- filerCIK 0001545414
Filing Metadata
- Form type
- 4
- Filed
- Jun 17, 8:00 PM ET
- Accepted
- Jun 18, 9:01 PM ET
- Size
- 8.2 KB